SU5416 and Doxorubicin in Treating Patients With Stage IIIB or Stage IV Inflammatory Breast Cancer

This study has been completed.

Study NCT00005822 Information provided by National Cancer Institute (NCI)

First Received: June 2, 2000 Last Updated: March 5, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	No date given
Primary Completion Date:	October 2003 (Final data collection date for primary outcome measure)